Skip to main content

Pain Measurement

1
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Medical Developments International
1 program
1
MethoxyfluranePhase 41 trial
Active Trials
NCT00524927Completed110Est. Nov 2009
Martin Pharmaceuticals
1 program
AlfentanilN/A1 trial
Active Trials
NCT01094574Completed10Est. Aug 2010
Design Pharmaceuticals
1 program
Qualitative Study for Pain Measurement Using Innovative Health TechnologyN/A1 trial
Active Trials
NCT03727373Completed8Est. Nov 2018
Design Therapeutics
1 program
Qualitative Study for Pain Measurement Using Innovative Health TechnologyN/A
Spine BioPharma
Spine BioPharmaNY - New York
1 program
Quantitative sensory testingN/A1 trial
Active Trials
NCT04888026Completed87Est. Mar 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Medical Developments InternationalMethoxyflurane
Spine BioPharmaQuantitative sensory testing
Design PharmaceuticalsQualitative Study for Pain Measurement Using Innovative Health Technology
Martin PharmaceuticalsAlfentanil

Clinical Trials (4)

Total enrollment: 215 patients across 4 trials

NCT00524927Medical Developments InternationalMethoxyflurane

Safety and Efficacy of Methoxyflurane for Treatment of Incident Pain

Start: Sep 2007Est. completion: Nov 2009110 patients
Phase 4Completed
NCT04888026Spine BioPharmaQuantitative sensory testing

Impact on Pain Sensitivity of Clinical Interaction

Start: May 2021Est. completion: Mar 202287 patients
N/ACompleted
NCT03727373Design PharmaceuticalsQualitative Study for Pain Measurement Using Innovative Health Technology

Qualitative Study for Pain Measurement Using Innovative Health Technology

Start: Oct 2018Est. completion: Nov 20188 patients
N/ACompleted
NCT01094574Martin PharmaceuticalsAlfentanil

Evaluation of Propranolol's Effect on Pain and Inflammation.

Start: Jan 2010Est. completion: Aug 201010 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.